1. Watkins RR, David MZ. Approach to the Patient with a Skin and Soft Tissue Infection. Infectious Disease Clin North America 2021; 35 (1): 1-48.
2. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious
Diseases Society of America. Clin Infect Dis. 2014;59(2):10-52.
3. Pasternak MS, Swartz MN. Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections In: Mandel GL, Bennett EJ, Dolin R, eds. Mandell, Douglas, and Ben-
nett’s Principles and Practice Infectious Diseases. 7th ed: Philadelphia: Churchill Livingstone, 2010:1289-312.
4. Breyre A, Frazee BW. Skin and soft tissue infections in the emergency department. Emerg Med Clin N Am 2018;36: 723-50.
5. Ramakrıshan K, Salinas RC, Hıguita NIA. Skin and soft tissue infections. Am Family Physian 2015;92(6):474-88.
6. Ak Ö, Diktaş H, Şenbayrak S, Saltoğlu N. Deri ve yumuşak doku infeksiyonları tanı ve tedavi. KLİMİK Dergisi 2020; 33(3): 200-12.
7. Saltoğlu N, Kılıçoğlu Ö, Baktıroğlu S, ve ark. Diyabetik ayak yarası ve enfeksiyonunun tanısı, tedavisi ve önlenmesi: Ulusal Uzlaşı Raporu. KLİMİK Dergisi 2015; 28
(Özel sayı 1):2-34.
8. Dündar D, Willke A, Sayan M, et al. Epidemiological and molecular characteristics of meticillin-resistant Staphylococcus aureus in Turkey: A multicentre study. J Glob
Antimicrob Resist . 2016;6: 44-9
9. Gillet Y, Mathie Lorrot M, Minodier P, Ouziel A , Haas H, Cohen R. Antimicrobial treatment of skin and soft tissue infections Infect Dis Now. 2023; 53 ( 8) Supplement.
https://doi.org/10.1016/j.idnow.2023.104787.
10. Schmitz GR, Bruner D, Pitotti R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for commu-
nity-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med 2010; 56:283.
11. Daum RS, Miller LG, Immergluck L, et al. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med 2017; 376:2545.
12. Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA 2016; 316:325.
13. Bouza E, Burillo A, Muñoz P. How to manage skin and soft-tissue infections in the emergency department. Current Opinion Infect Dis.. 2023; 36(2): 81-88.
14. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: Expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;
52(Suppl. 1): i3-17.
15. Burnham JP and Kollef MH. Treatment of severe skin and soft tissue infections: a review. Curr Opin Infect Dis. 2018; 31(2): 113–119.
16. Petermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol
Infect. 2020 Jan;26(1):8-17. doi: 10.1016/j.cmi.2019.06.031. Epub 2019
17. Fatimah L.Necrotizing Fasciitis: How Reliable are the Cutaneous Signs? J Emerg Trauma Shock., 2017; 10(4): 205–210.
18. Damisa J, Ahmed S, Harrison S. Necrotising fasciitis: a narrative review of the literature. Br J Hosp Med (Lond). 2021; 82(4): 1–9.
19. Yi-Shi Wang 1, Chin-Ho Wong, Yong-Kwang Tay. Staging of necrotizing fasciitis based on the evolving cutaneous features International J Dermatology 2007, 46 ,
1036–1041.
20. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) Score: a tool for distinguishing necrotizing fasciitis from other
soft tissue infections. Crit Care Med 2004; 32: 15351541.
21. Gottlieb M, DeMott JM, Hallock M, Peksa GD. Systemic Antibiotics for the Treatment of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis. Ann
Emerg Med 2019; 73:8.
22. Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med 2017;377: 2253e65.
23. Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J
Emerg Surg 2018;13:58.
24. Stieferman AE, Mazi P, Burnham JP. Severe Skin and Soft-Tissue Infections. Semin Respir Crit Care Med 2022; 43(01): 003-009
25. Moffarah AS, Al Mohajer M, Hurwitz BL, Armstrong DG. Skin and soft tissue infections. 2016. Microbiol Spectrum 4(4): DMIH2-0014-2015.
26. Shivan Shah, Samuel Shelburne. Skin and Soft Tissue Infections in Non–Human Immunodeficiency Virus Immunocompromised Hosts. Infectious Disease Clinics of
North America. 2021; 35 (1): 199-217.
27. Brook I. Management of human and animal bites wounds. Adv Scin Wound Care. 2005; 18:197-203.
28. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health. 2010;3(3):98-105.
29. Doganay M, Metan G. Human anthrax in Turkey from 1990 to 2007. Vector Borne Zoonotic Dis. 2009;9(2):131-40.
30. Akalın H, Helvacı S, Gedikoğlu S. Re-emergence of tularemia in Turkey. International J of Infect Dis 2009; 13: 547-51.
31. Magill AJ. Leishmania Species: Visceral (Kala-Azar), Cutaneous, and Mucosal Leishmaniasis In:Mandel GL, Bennett EJ, Dolin R, eds. Mandell, Douglas, and Bennett’s
Principles and Practice Infectious Diseases. 7th ed: Philadelphia: Churchill Livingstone, 2010: 3463-80.
32. Maggi R. Bartonella. In:Mandel GL, Bennett EJ, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice Infectious Diseases. 7th ed: Philadelphia: Chur-
chill Livingstone, 2010:1289-312.
33. Wellinghausen N. Listeria and Erysipelothrix. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry LM, Warnock DW eds. Manual of Clinical Microbiology.
10th ed. Washington DC: American Society for Microbiology, 2011: 403-408